WiQo

WiQo is a leading Italian aesthetic medicine company that specializes in the development and distribution of non-invasive skin rejuvenation treatments and advanced cosmeceuticals. Founded in 1994 by dermatologist Dr. Rossana Castellana, the company is globally recognized for its patented PRX-T33 (now PRX Derm Perfexion) treatment, a needle-free chemical biostimulator that combines trichloroacetic acid and hydrogen peroxide to promote skin regeneration without downtime. WiQo's portfolio includes a variety of medical devices and skincare products designed to address indications such as skin laxity, hyperpigmentation, and scarring. Headquartered in Trieste, Italy, the company maintains a presence in over 60 countries and was acquired by the healthcare-focused private equity firm ARCHIMED in 2023 to accelerate its international expansion. The company continues to innovate in the field of topical biostimulation, providing professional-grade solutions for dermatologists and aesthetic practitioners worldwide.